Close Menu

skin cancer

The report cited cost and a lack of awareness of such testing among doctors as the main obstacles to greater adoption of MDx testing for cancer patients.

Researchers from the Sanger Institute used genomic sequencing to study how somatic mutations build up prior to becoming cancerous. 

A new genome-wide association study used imputation to test millions of variants in basal cell carcinoma cases and controls from Iceland.

NEW YORK (GenomeWeb News) – Verisante Technology said this week that it has begun submitting an application to the US Food and Drug Administration for 510(k) clearance of its Aura skin cancer detection device.

NEW YORK (GenomeWeb) – EKF Diagnostics Holdings today said it and Massachusetts General Hospital have entered into a two-year research collaboration to develop EFK's PointMan assays for certain cancers.

NEW YORK (GenomeWeb) – Biocartis today announced it has obtained CE-IVD marking for and commercially launched the Idylla molecular diagnostics platform and BRAF Mutation Test.

NEW YORK (GenomeWeb News) – Verisante Technology last week posted a sharp drop in Q1 2014 revenues, as the firm terminated its Canadian distributor agreement for its Raman spectroscopy-based Aura skin cancer detection device, choosing instead to pursue a direct sales approach.

NEW YORK (GenomeWeb) – Melanoma test development firm DermTech International has filed to go public with a proposed offering of up to $25 million in stock.

Verisante Technology last week reported second quarter revenues of C$178,000 ($170,000), all from sales of its Aura skin cancer detection device.

Verisante Technology said this week it has signed an exclusive distribution deal with Pacifica Handels to distribute its Aura skin cancer detection device in Switzerland.

Pages

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.